Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™

Go back to Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
(NASDAQ: NTRA) Delayed: 369.39 +3.08 (0.84%)
Previous Close $366.31    52 Week High $13.80 
Open $365.78    52 Week Low $6.52 
Day High $369.69    P/E N/A 
Day Low $358.90    EPS $0.00 
Volume 3,718,171